Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Seppo Yla-Herttuala

Molecular Medicine Research Group, A. I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland

Academy Professor Seppo Ylä-Herttuala is a pioneer and international leader in cardiovascular gene therapy. He was the first in the world to apply adenoviral gene transfer to human arteries in 1995. Since then he has developed both gene transfer vectors and production systems and a highly successful research team focusing on angiogenesis, VEGF biology and its clinical applications.

Relevant Topics

Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

arrow_upward arrow_upward